HEALTH● LOW3h ago · Oct 13, 2026, 9:37 PM
AbbVie releases phase 3 induction therapy data on injectable Skyrizi for Crohn's
Seeking Alpha Tech · global
AbbVie has released phase 3 induction therapy data for its injectable drug Skyrizi, developed for the treatment of Crohn's disease. This provides an update on the clinical development of a potential new medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoLouis Prevost, one of the brothers of Pope Leo XIV, is also hospitalized with cancerClarínHEALTH1h agoPope Leo recovering from surgery at hospital amid lung cancer diagnosisCBS NewsHEALTH1h agoWhat to know about pulmonary adenocarcinomaWashington Post WorldHEALTH1h agoDetails on Pope Leo XIV's lung cancer diagnosis, surgeryCBS News